HomepageBlogEvonik Plans Further Investment in mRNA Field to Expand Applications Beyond COVID-19 Vaccine Blog IndustryEvonik Plans Further Investment in mRNA Field to Expand Applications Beyond COVID-19 Vaccine admin Posted on August 14, 2023 Evonik Industries AG supplies lipids essential to production of the Pfizer–BioNTech COVID-19 vaccine, in which messenger RNA (mRNA) is enclosed……Please subscribe to read the full story.Author admin View all posts Post navigationPrevious PostMitsubishi Chemical to Mass-Produce GaN Substrates for More Energy-Efficient Vehicles, Devices Next PostJSR to Boost Production Capacity for Advanced Semiconductor PhotoresistsYou Might Also Like BlogInterview: Dow Thailand President Chatchai Luanpolcharoenchai Reflects on 2020, Discusses Possibilities Moving Forward admin August 14, 2023 BlogRecycled, Bio-Based Resins Hit Growth Plateau Amid COVID-19 admin August 14, 2023 BlogMitsui Chemicals Turns to Microwave Technology for Chemical Recycling admin August 14, 2023 BlogInterview: New Mitsui Chemicals President Osamu Hashimoto Looks to the Future admin August 14, 2023
BlogInterview: Dow Thailand President Chatchai Luanpolcharoenchai Reflects on 2020, Discusses Possibilities Moving Forward admin August 14, 2023
BlogInterview: New Mitsui Chemicals President Osamu Hashimoto Looks to the Future admin August 14, 2023